Shanghai builds a full-cycle capital ecosystem to back biotech companies
The initiative reflects an effort to move from investing in individual biotech projects to building an ecosystem around them.
The initiative reflects an effort to move from investing in individual biotech projects to building an ecosystem around them.

The growth is fueled by high-value strategic partnerships and the park’s focus on proprietary intellectual property.

The company says its approach helps reduce manufacturing risks that often emerge during large-scale production.